AU2292600A - Varicella-zoster virus vaccines - Google Patents

Varicella-zoster virus vaccines

Info

Publication number: AU2292600A
Authority: AU; Australia
Prior art keywords: varicella; zoster virus; virus vaccines; vaccines; zoster
Prior art date: 1999-01-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU22926/00A

Inventor

Alex Bollen

Michele Haumont

Paul Jacobs

Alain Jacquet

Marc Georges Francis Massaer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

GlaxoSmithKline Biologicals SA

Original Assignee

SmithKline Beecham Biologicals SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-20

Filing date

2000-01-17

Publication date

2000-08-07

2000-01-17 Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA

2000-08-07 Publication of AU2292600A publication Critical patent/AU2292600A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

AU22926/00A 1999-01-20 2000-01-17 Varicella-zoster virus vaccines Abandoned AU2292600A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9901254		1999-01-20
GBGB9901254.4A GB9901254D0 (en)	1999-01-20	1999-01-20	Vaccines
PCT/EP2000/000352 WO2000043527A1 (en)	1999-01-20	2000-01-17	Varicella-zoster virus vaccines

Publications (1)

Publication Number	Publication Date
AU2292600A true AU2292600A (en)	2000-08-07

Family

ID=10846213

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU22926/00A Abandoned AU2292600A (en)	1999-01-20	2000-01-17	Varicella-zoster virus vaccines

Country Status (5)

Country	Link
AR (1)	AR027484A1 (en)
AU (1)	AU2292600A (en)
CO (1)	CO5241364A1 (en)
GB (1)	GB9901254D0 (en)
WO (1)	WO2000043527A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0504436D0 (en) *	2005-03-03	2005-04-06	Glaxosmithkline Biolog Sa	Vaccine
AU2012213948B2 (en) *	2005-03-03	2016-01-21	Glaxosmithkline Biologicals S.A.	Vaccine
US20100330122A1 (en) *	2007-07-19	2010-12-30	Gale Smith	VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES (VLPs) AND ANTIGENS
KR20140007404A (en) *	2011-01-31	2014-01-17	더 트러스티스 오브 더 유니버시티 오브 펜실바니아	Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
KR101723605B1 (en) *	2014-10-21	2017-04-07	진원생명과학 주식회사	Dna vaccine composition for preventing and treating herpes zoster and method of activating t-cell to vzv antizen by using the same
CN110035772B (en) *	2016-11-25	2023-07-18	财团法人牧岩生命科学研究所	Varicella Zoster Virus Vaccine
WO2018097642A1 (en) *	2016-11-25	2018-05-31	재단법인 목암생명과학연구소	Varicella zoster virus vaccine
CN112142828B (en) *	2019-06-28	2022-02-01	怡道生物科技(苏州)有限公司	gE gene and vector for expressing the gene
AU2020403296B2 (en) *	2019-12-13	2025-03-06	Grand Theravac Life Science (Nanjing) Co., Ltd.	Immunostimulatory composition and use thereof
CN115819616B (en) *	2021-07-28	2025-04-11	江苏瑞科生物技术股份有限公司	A gene recombinant VZV fusion protein and its preparation method and application
JP2024541466A (en)	2021-11-24	2024-11-08	フラッグシップパイオニアリングイノベーションズシックス，エルエルシー	Varicella-zoster virus immunogenic composition and uses thereof
CN114891830B (en) *	2022-04-02	2024-03-01	武汉博沃生物科技有限公司	Recombinant expression vector based on varicella-zoster virus, recombinant virus and application thereof
CN114767844B (en) *	2022-04-28	2025-12-23	泰州拜奥生物技术有限公司	Varicella-zoster virus vaccine and application thereof
EP4653469A1 (en) *	2023-01-19	2025-11-26	Xiamen University	Fusion protein of ge and gi of varicella-zoster virus and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0405867B1 (en) *	1989-06-27	1995-03-15	SMITHKLINE BEECHAM BIOLOGICALS s.a.	Novel compounds
GB9226768D0 (en) *	1992-12-23	1993-02-17	Smithkline Beecham Biolog	Vaccines
GB9413751D0 (en) *	1994-07-07	1994-08-24	British Bio Technology	Immunodominant peptides
IL125440A (en) *	1996-02-09	2002-02-10	Smithkline Beecham Biolog	Vaccines against varicella zoster virus gene ie-63 product

1999
- 1999-01-20 GB GBGB9901254.4A patent/GB9901254D0/en not_active Ceased
2000
- 2000-01-17 WO PCT/EP2000/000352 patent/WO2000043527A1/en not_active Ceased
- 2000-01-17 AU AU22926/00A patent/AU2292600A/en not_active Abandoned
- 2000-01-18 AR ARP000100224A patent/AR027484A1/en unknown
- 2000-01-20 CO CO00002923A patent/CO5241364A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
GB9901254D0 (en)	1999-03-10
CO5241364A1 (en)	2003-01-31
AR027484A1 (en)	2003-04-02
WO2000043527A1 (en)	2000-07-27

Publication	Publication Date	Title
GB2337755B (en)	2003-10-29	Virus vaccine
SI1410805T1 (en)	2006-04-30	Vaccine against HPV
HUP0202885A3 (en)	2004-07-28	Vaccines
IL145043A0 (en)	2002-06-30	Vaccine
HUS1300072I1 (en)	2019-11-28	Vaccine
AU2292600A (en)	2000-08-07	Varicella-zoster virus vaccines
AU5977700A (en)	2001-01-31	Vaccines
AU1600401A (en)	2001-06-06	Malaria vaccine
AU6158700A (en)	2001-01-30	Vaccine
AU4957800A (en)	2000-12-18	Vaccine against isa virus
AU5811600A (en)	2000-12-28	Vaccine
GB9925432D0 (en)	1999-12-29	Virus preparation
GB9930591D0 (en)	2000-02-16	Component for vaccine
GB9906437D0 (en)	1999-05-12	Vaccine
AU5084300A (en)	2000-12-12	New vaccine formulations - 1
GB9930585D0 (en)	2000-02-16	Component for vaccine
AU4935700A (en)	2000-12-12	New vaccine formulations-3
GB9925434D0 (en)	1999-12-29	Virus Preparation
GB9917981D0 (en)	1999-09-29	Viral vaccine
GB9909072D0 (en)	1999-06-16	Vaccine
GB9922700D0 (en)	1999-11-24	Vaccine
GB9909466D0 (en)	1999-06-23	Vaccines
GB9904280D0 (en)	1999-04-21	Vaccines
GB9904048D0 (en)	1999-04-14	Vaccines
SI1155119T1 (en)	2007-02-28	Bhv-1 gene-deleted virus vaccine

Legal Events

Date	Code	Title	Description
2000-12-07	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase